PKN2 and cancer: Indeed, we recently contributed to work identifying that PKN2 and ROCK1 collaborate to mediate rear end retraction in durotaxis (Hetmanski et al., 2019), focusing on mesenchymal migratory cancer cell models, a process which also requires mechanical activation of YAP (Lachowski et al., 2018).